Evidence map›Paper›PMID 33430324›Full record

ArticleAntioxidants (Basel, Switzerland)2021

Water Soluble Iron-Based Coordination Trimers as Synergistic Adjuvants for Pancreatic Cancer.

Marco Cordani, Esther Resines-Urien, Arturo Gamonal, Paula Milán-Rois, Lionel Salmon, Azzedine Bousseksou, Jose Sanchez Costa, Álvaro Somoza

Open access · goldAbstract read
In one paragraph

Article in Antioxidants (Basel, Switzerland), 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.1field-weighted citation impact, top 20% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 15 citations in OpenAlex.

  1. Review
  2. Review
  3. Review
  4. Review
  5. Article
  6. Review
  7. Paradox Role of Oxidative Stress in Cancer: State of the Art.Antioxidants (Basel, Switzerland) · 2022
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors at 2 institutions in 2 countries.

Marco CordaniIMDEA Nanociencia, Faraday 9, Ciudad Universitaria de Cantoblanco, 28049 Madrid, Spain.ORCID 0000-0001-9342-4862
Esther Resines-UrienIMDEA Nanociencia, Faraday 9, Ciudad Universitaria de Cantoblanco, 28049 Madrid, Spain.
Arturo GamonalIMDEA Nanociencia, Faraday 9, Ciudad Universitaria de Cantoblanco, 28049 Madrid, Spain.
Paula Milán-RoisIMDEA Nanociencia, Faraday 9, Ciudad Universitaria de Cantoblanco, 28049 Madrid, Spain.
Lionel SalmonLaboratoire de Chimie de Coordination, UPR8241, 205 Route de Narbonne, CEDEX 4, 31077 Toulouse, France.
Azzedine BousseksouLaboratoire de Chimie de Coordination, UPR8241, 205 Route de Narbonne, CEDEX 4, 31077 Toulouse, France.
Jose Sanchez CostaIMDEA Nanociencia, Faraday 9, Ciudad Universitaria de Cantoblanco, 28049 Madrid, Spain.
Álvaro SomozaIMDEA Nanociencia, Faraday 9, Ciudad Universitaria de Cantoblanco, 28049 Madrid, Spain.ORCID 0000-0001-9873-435X
IMDEA Nanoscience · ESLaboratoire de Chimie de Coordination · FR

Funding

FACILITY FOR MED UNIV OF SC CTR FOR SUBST ABUSE RESEARCHC06DA007809 · NIDA · MEDICAL UNIVERSITY OF SOUTH CAROLINA · PI BALLENGER, JAMES C · 1991 to 1991
–
Comunidad de Madrid IND2017/IND-7809, PEJD-2017-PRE/IND-4037, P2018/NMT-4321Fundación Científica Asociación Española Contra el Cáncer N/AIMDEA Nanociencia N/AMinisterio de Economía y Competitividad SAF2017-87305-R, CTQ2016-80635-P, RYC-2014-16866Ministerio de Economía y Competitividad SEV-2016-0686
6 · The paper itself

Abstract

Pancreatic cancer is a usually fatal disease that needs innovative therapeutic approaches since the current treatments are poorly effective. In this study, based on cell lines, triazole-based coordination trimers made with soluble Fe(II) in an aqueous media were explored for the first time as adjuvant agents for the treatment of this condition. These coordination complexes were effective at relatively high concentrations and led to an increase in reactive oxygen species (ROS) in two pancreatic cancer cell lines, PANC-1 and BXPC-3, and this effect was accompanied by a significant reduction in cell viability in the presence of gemcitabine (GEM). Importantly, the tested compounds enhanced the effect of GEM, an approved drug for pancreatic cancer, through apoptosis induction and downregulation of the mTOR pathway. Although further evaluation in animal-based models of pancreatic cancer is needed, these results open novel avenues for exploring these iron-based materials in biomedicine in general and in pancreatic cancer treatment.

Indexed as

antitumor agentsbioinorganic chemistrycoordination polymerspancreatic cancerreactive oxygen species

Identifiers

PMID33430324
PMCPMC7825762
OpenAlexW3120740684

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.